Westfield Capital Management CO LP Alkermes Plc. Transaction History

Westfield Capital Management CO LP

  • $21.2 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$23.21 - $27.24 $785,983 - $922,455
33,864 Added 2.64%
1,316,605 $31.7 Million
Q1 2024

May 10, 2024
SELL
$26.4 - $32.56 $9.06 Million - $11.2 Million
-343,042 Reduced 21.1%
1,282,741 $34.7 Million
Q4 2023

Feb 09, 2024
SELL
$23.37 - $28.68 $1.02 Million - $1.26 Million
-43,830 Reduced 2.63%
1,625,783 $45.1 Million
Q3 2023

Nov 13, 2023
SELL
$27.17 - $31.97 $17.5 Million - $20.6 Million
-645,697 Reduced 27.89%
1,669,613 $46.8 Million
Q2 2023

Aug 11, 2023
SELL
$28.34 - $33.63 $35.7 Million - $42.3 Million
-1,259,158 Reduced 35.23%
2,315,310 $72.5 Million
Q1 2023

May 12, 2023
BUY
$25.31 - $29.02 $4.78 Million - $5.48 Million
188,998 Added 5.58%
3,574,468 $101 Million
Q4 2022

Feb 13, 2023
BUY
$21.94 - $26.24 $25 Million - $29.9 Million
1,138,816 Added 50.69%
3,385,470 $88.5 Million
Q3 2022

Nov 14, 2022
BUY
$22.0 - $31.87 $18.2 Million - $26.4 Million
829,275 Added 58.51%
2,246,654 $50.2 Million
Q2 2022

Aug 12, 2022
BUY
$26.4 - $30.54 $36.8 Million - $42.6 Million
1,393,434 Added 5819.31%
1,417,379 $42.2 Million
Q1 2022

May 16, 2022
BUY
$23.07 - $27.99 $552,411 - $670,220
23,945 New
23,945 $630,000

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email